These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24530150)

  • 1. Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey.
    Knight-Jones TJ; Bulut AN; Gubbins S; Stärk KD; Pfeiffer DU; Sumption KJ; Paton DJ
    Vaccine; 2014 Apr; 32(16):1848-55. PubMed ID: 24530150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the performance of foot-and-mouth disease vaccines prepared against local strains in the face of antigenic evolution in the field.
    Tuncer-Göktuna P; Çokçalışkan C; Arslan A; Taşçene N; Uzun EA; Gündüzalp C; Balcı GN; Kara O; Gülyaz V
    Transbound Emerg Dis; 2021 Mar; 68(2):648-655. PubMed ID: 32677765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled field trial assessing foot and mouth disease vaccine effectiveness in Gondar Zuria district, Northwest Ethiopia.
    Jemberu WT; Molla W; Fentie T
    Prev Vet Med; 2020 Oct; 183():105136. PubMed ID: 32977170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.
    Elnekave E; Li Y; Zamir L; Even-Tov B; Hamblin P; Gelman B; Hammond J; Klement E
    Vaccine; 2013 Jan; 31(6):879-85. PubMed ID: 23246551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a polyvalent foot-and-mouth disease virus vaccine containing A Saudi-95 against field challenge on large-scale dairy farms in Saudi Arabia with the emerging A/ASIA/G-VII viral lineage.
    Lyons NA; Ludi AB; Wilsden G; Hamblin P; Qasim IA; Gubbins S; King DP
    Vaccine; 2017 Dec; 35(49 Pt B):6850-6857. PubMed ID: 29108665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological analysis of an outbreak of foot-and-mouth disease (serotype SAT2) on a large dairy farm in Kenya using regular vaccination.
    Lyons NA; Stärk KD; van Maanen C; Thomas SL; Chepkwony EC; Sangula AK; Dulu TD; Fine PE
    Acta Trop; 2015 Mar; 143():103-11. PubMed ID: 25447264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.
    Knight-Jones TJ; Bulut AN; Gubbins S; Stärk KD; Pfeiffer DU; Sumption KJ; Paton DJ
    Vaccine; 2015 Feb; 33(6):805-11. PubMed ID: 25528523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of vaccines and vaccination programs for the control of foot-and-mouth disease in Uganda, 2001-2010.
    Muleme M; Barigye R; Khaitsa ML; Berry E; Wamono AW; Ayebazibwe C
    Trop Anim Health Prod; 2013 Jan; 45(1):35-43. PubMed ID: 22956440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of foot and mouth disease hotspots in northern Lao PDR.
    Nampanya S; Richards J; Khounsy S; Inthavong P; Yang M; Rast L; Windsor PA
    Transbound Emerg Dis; 2013 Aug; 60(4):315-29. PubMed ID: 22690839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of foot and mouth disease (FMD) vaccine using registered surveillance data.
    Emami SJ; Bahonar AR; Mehrabadi MHF; Lotfollazadeh S; Amiri K; Abdollahi D
    Trop Anim Health Prod; 2022 Jun; 54(4):215. PubMed ID: 35723776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effectiveness of foot-and-mouth disease vaccination of animals in the buffer zone of the Republic of Armenia in 2016-2020.
    Kharatyan S; Sargsyan K; Elbakyan H; Markosyan T; Tumanyan P; Hakobyan V; Sargsyan V; Badalyan M; Chobanyan G; Achenbach JE
    BMC Vet Res; 2023 Sep; 19(1):176. PubMed ID: 37773157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection in sheep against heterologous challenge with serotype Asia-1 foot-and-mouth disease virus using high potency vaccine.
    Horsington J; Nfon C; Gonzales JL; Singanallur N; Bittner H; Vosloo W
    Vaccine; 2018 Oct; 36(41):6095-6102. PubMed ID: 30195485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
    Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with within-herd transmission of serotype A foot-and-mouth disease virus in cattle, during the 2001 outbreak in Argentina: a protective effect of vaccination.
    Brito BP; Perez AM; Cosentino B; Rodriguez LL; König GA
    Transbound Emerg Dis; 2011 Oct; 58(5):387-93. PubMed ID: 21896154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long term effect of age and maternally derived antibodies against foot and mouth disease on the serological response following vaccination in young dairy calves.
    Elnekave E; Dekker A; Eble P; van Hemert-Kluitenberg F; Gelman B; Storm N; Klement E
    Vaccine; 2016 Sep; 34(41):4927-4934. PubMed ID: 27521229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
    Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies II: Waiting Periods After Emergency Vaccination in FMD Free Countries.
    Geale DW; Barnett PV; Clarke GW; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):388-406. PubMed ID: 24131661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for foot and mouth disease outbreaks in grazing beef cattle herds.
    Elnekave E; Zamir L; Hamd F; Even Tov B; Klement E
    Prev Vet Med; 2015 Jun; 120(2):236-240. PubMed ID: 25841998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage.
    Waters R; Ludi AB; Fowler VL; Wilsden G; Browning C; Gubbins S; Statham B; Bin-Tarif A; Mioulet V; King DJ; Colenutt C; Brown E; Hudelet P; King DP
    Vaccine; 2018 Mar; 36(14):1901-1907. PubMed ID: 29506922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the level of herd infection for outbreaks of foot-and-mouth disease in vaccinated herds.
    Hutber AM; Kitching RP; Conway DA
    Epidemiol Infect; 1999 Jun; 122(3):539-44. PubMed ID: 10459659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.